UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model

Journal of pharmacokinetics and pharmacodynamics, 2007-02, Vol.34 (1), p.57-85

2007

Volltextzugriff (PDF)

Population pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females

International journal of clinical pharmacology and therapeutics, 2006-12, Vol.44 (12), p.655-667

2006

Volltextzugriff (PDF)

Pharmacometrics : modelling and simulation tools to improve decision making in clinical drug development

European journal of drug metabolism and pharmacokinetics, 2000-01, Vol.25 (1), p.49-58

2000

Volltextzugriff (PDF)

Role of modelling and simulation in Phase I drug development

European journal of pharmaceutical sciences, 2001-05, Vol.13 (2), p.115-122

2001

Volltextzugriff (PDF)

Population pharmacokinetic analysis of the major metabolites of capecitabine

Journal of pharmacokinetics and pharmacodynamics, 2002-02, Vol.29 (1), p.25-47

2002

Volltextzugriff (PDF)

Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modelling

International journal of clinical pharmacology and therapeutics, 1997-10, Vol.35 (10), p.469

1997

Volltextzugriff (PDF)

Sparse sampling for assessment of drug exposure in toxicological studies

European journal of drug metabolism and pharmacokinetics, 1996-04, Vol.21 (2), p.105-111

1996

Volltextzugriff (PDF)

Simultaneous Pharmacokinetic Modeling of a Drug and Two Metabolites: Application to Albendazole in Sheep

Journal of pharmaceutical sciences, 1991-01, Vol.80 (1), p.3-10

1991

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic data and models in clinical trials

European journal of drug metabolism and pharmacokinetics, 1993-01, Vol.18 (1), p.61-76

1993

Volltextzugriff (PDF)

Zero-order absorption and linear disposition of oral colchicine in healthy volunteers

European journal of clinical pharmacology, 1989, Vol.37 (1), p.79-84

1989

Volltextzugriff (PDF)

A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients

Cancer chemotherapy and pharmacology, 1991-01, Vol.28 (2), p.123-129

1991

Volltextzugriff (PDF)

Pharmacokinetic aspects of the sublingual administration of vincamine

Biopharmaceutics & drug disposition, 1990-05, Vol.11 (4), p.279-309

1990

Volltextzugriff (PDF)

Hyperparameter Estimation Using Stochastic Approximation with Application to Population Pharmacokinetics

Biometrics, 1988-09, Vol.44 (3), p.673-683

1988

Volltextzugriff (PDF)

A semimechanistic and mechanistic population PK–PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis

British journal of clinical pharmacology, 2004-12, Vol.58 (6), p.618-631

2004

Volltextzugriff (PDF)

Modelling and simulation in the development and use of anti-cancer agents : An underused tool?

Journal of pharmacokinetics and pharmacodynamics, 2004-12, Vol.31 (6), p.419-440

2004

Volltextzugriff (PDF)

Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine

Journal of pharmacokinetics and biopharmaceutics, 1988-06, Vol.16 (3), p.311-327

1988

Volltextzugriff (PDF)

Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125

Journal of pharmacokinetics and biopharmaceutics, 1994-10, Vol.22 (5), p.327-365

1994

Volltextzugriff (PDF)

Cytoplasmic and nuclear uptake of aldosterone in toad bladder: a mathematical modeling approach

American Journal of Physiology: Cell Physiology, 1985-01, Vol.248 (1), p.C88-C101

1985

Volltextzugriff (PDF)

Alternative Approaches to Estimation of Population Pharmacokinetic Parameters: Comparison with the Nonlinear Mixed-Effect Model

Drug metabolism reviews, 1984, Vol.15 (1-2), p.265-292

1984

Volltextzugriff (PDF)

A mathematical model of the kinetics of 5-fluorouracil and its catabolites in freshly isolated rat hepatocytes

Biochemical pharmacology, 1984-09, Vol.33 (17), p.2727-2732

1984

Volltextzugriff (PDF)

Description of the time course of the prolactin suppressant effect of the dopamine agonist CQP201‐403 by an integrated pharmacokinetic‐ pharmacodynamic model

British journal of clinical pharmacology, 1986-07, Vol.22 (1), p.1-13

1986

Volltextzugriff (PDF)

Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience

Investigational new drugs, 2003-05, Vol.21 (2), p.195-223

2003

Volltextzugriff (PDF)

Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response : application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922

Journal of pharmacokinetics and biopharmaceutics, 1991-06, Vol.19 (3), p.287-309

1991

Volltextzugriff (PDF)

A Time-Lag Model for Pharmacokinetics of Drugs Subject to Enterohepatic Circulation

Journal of pharmaceutical sciences, 1982-03, Vol.71 (3), p.297-302

1982

Volltextzugriff (PDF)

Finite element simulation of gas transport in proximal respiratory airways: Comparison with experimental data

Computers and biomedical research, 1981-12, Vol.14 (6), p.493-505

1981

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaModels, Biological

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(28)

Sprache

Englisch
(27)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model

Population pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females

Pharmacometrics : modelling and simulation tools to improve decision making in clinical drug development

Role of modelling and simulation in Phase I drug development

Population pharmacokinetic analysis of the major metabolites of capecitabine

Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modelling

Sparse sampling for assessment of drug exposure in toxicological studies

Simultaneous Pharmacokinetic Modeling of a Drug and Two Metabolites: Application to Albendazole in Sheep

Pharmacokinetic and pharmacodynamic data and models in clinical trials

Zero-order absorption and linear disposition of oral colchicine in healthy volunteers

A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients

Pharmacokinetic aspects of the sublingual administration of vincamine

Hyperparameter Estimation Using Stochastic Approximation with Application to Population Pharmacokinetics

A semimechanistic and mechanistic population PK–PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis

Modelling and simulation in the development and use of anti-cancer agents : An underused tool?

Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine

Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125

Cytoplasmic and nuclear uptake of aldosterone in toad bladder: a mathematical modeling approach

Alternative Approaches to Estimation of Population Pharmacokinetic Parameters: Comparison with the Nonlinear Mixed-Effect Model

A mathematical model of the kinetics of 5-fluorouracil and its catabolites in freshly isolated rat hepatocytes

Description of the time course of the prolactin suppressant effect of the dopamine agonist CQP201‐403 by an integrated pharmacokinetic‐ pharmacodynamic model

Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience

Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response : application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922

A Time-Lag Model for Pharmacokinetics of Drugs Subject to Enterohepatic Circulation

Finite element simulation of gas transport in proximal respiratory airways: Comparison with experimental data

Aktive Filter

Suchergebnisse filtern